{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:32:57Z","timestamp":1791203577575,"version":"4.2.0"},"reference-count":75,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T00:00:00Z","timestamp":1658793600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K08DA049905"],"award-info":[{"award-number":["K08DA049905"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["UG1DA015815"],"award-info":[{"award-number":["UG1DA015815"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["R01HS026215"],"award-info":[{"award-number":["R01HS026215"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["shmpublications.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hospital Medicine"],"published-print":{"date-parts":[[2022,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Hospitalizations related to the consequences of opioid use are rising. National guidelines directing in\u2010hospital opioid use disorder (OUD) management do not exist. OUD treatment guidelines intended for other treatment settings could inform in\u2010hospital OUD management.<\/jats:p><\/jats:sec><jats:sec><jats:title>Objective<\/jats:title><jats:p>Evaluate the quality and content of existing guidelines for OUD treatment and management.<\/jats:p><\/jats:sec><jats:sec><jats:title>Data Sources<\/jats:title><jats:p>OVID MEDLINE, PubMed, Ovid PsychINFO, EBSCOhost CINHAL, ERCI Guidelines Trust, websites of relevant societies and advocacy organizations, and selected international search engines.<\/jats:p><\/jats:sec><jats:sec><jats:title>Study Selection<\/jats:title><jats:p>Guidelines published between January 2010 to June 2020 addressing OUD treatment, opioid withdrawal management, opioid overdose prevention, and care transitions among adults.<\/jats:p><\/jats:sec><jats:sec><jats:title>Data Extraction<\/jats:title><jats:p>We assessed quality using the Appraisal of Guidelines for Research and Evaluation (AGREE) II instrument.<\/jats:p><\/jats:sec><jats:sec><jats:title>Data Synthesis<\/jats:title><jats:p>Nineteen guidelines met the selection criteria. Most recommendations were based on observational studies or expert consensus. Guidelines recommended the use of nonstigmatizing language among patients with OUD; to assess patients with unhealthy opioid use for OUD using the <jats:italic>Diagnostic Statistical Manual of Diseases<\/jats:italic>\u20145th Edition criteria; use of methadone or buprenorphine to treat OUD and opioid withdrawal; use of multimodal, nonopioid therapy, and when needed, short\u2010acting opioid analgesics in addition to buprenorphine or methadone, for acute pain management; ensuring linkage to ongoing methadone or buprenorphine treatment; referring patients to psychosocial treatment; and ensuring access to naloxone for opioid overdose reversal.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Included guidelines were informed by studies with various levels of rigor and quality. Future research should systematically study buprenorphine and methadone initiation and titration among people using fentanyl and people with pain, especially during hospitalization.<\/jats:p><\/jats:sec>","DOI":"10.1002\/jhm.12908","type":"journal-article","created":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T16:22:41Z","timestamp":1658852561000},"page":"679-692","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Management of opioid use disorder, opioid withdrawal, and opioid overdose prevention in hospitalized adults: A systematic review of existing guidelines"],"prefix":"10.1002","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0584-7783","authenticated-orcid":false,"given":"Susan L.","family":"Calcaterra","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of General Internal Medicine and Division of Hospital Medicine University of Colorado  Aurora Colorado USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4110-1628","authenticated-orcid":false,"given":"Richard","family":"Bottner","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine Dell Medical School at The University of Texas at Austin  Austin Texas USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8727-0289","authenticated-orcid":false,"given":"Marlene","family":"Martin","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hospital Medicine University of California San Francisco and San Francisco General Hospital  San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honora","family":"Englander","sequence":"additional","affiliation":[{"name":"Department of Medicine, Section of Addiction Medicine and Division of Hospital Medicine Oregon Health &amp; Science University  Portland Oregon USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe M.","family":"Weinstein","sequence":"additional","affiliation":[{"name":"Department of Medicine, Boston Medical Center, Section of General Internal Medicine, Clinical Addiction Research and Education (CARE) Unit Boston University School of Medicine  Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa B.","family":"Weimer","sequence":"additional","affiliation":[{"name":"Department of Medicine Yale School of Medicine  New Haven Connecticut USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Lambert","sequence":"additional","affiliation":[{"name":"Department of Medicine Harvard Medical School  Boston Massachusetts USA"},{"name":"Department of Medicine Massachusetts General Hospital  Charlestown Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0872-1924","authenticated-orcid":false,"given":"Matthew V.","family":"Ronan","sequence":"additional","affiliation":[{"name":"Department of Medicine Harvard Medical School  Boston Massachusetts USA"},{"name":"Department of Medicine Massachusetts General Hospital  Charlestown Massachusetts USA"},{"name":"Department of Medicine VA Boston Healthcare System  West Roxbury Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Huerta","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Hospital Medicine University of New Mexico School of Medicine  Albuquerque New Mexico USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tauheed","family":"Zaman","sequence":"additional","affiliation":[{"name":"San Francisco VA Medical Center  San Francisco California USA"},{"name":"Department of Psychiatry and Behavioral Sciences University of California San Francisco  San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monish","family":"Ullal","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine at Highland Hospital Alameda Health System  Oakland California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alyssa F.","family":"Peterkin","sequence":"additional","affiliation":[{"name":"Department of Medicine, Boston Medical Center, Section of General Internal Medicine, Clinical Addiction Research and Education (CARE) Unit Boston University School of Medicine  Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine","family":"Torres\u2010Lockhart","sequence":"additional","affiliation":[{"name":"Albert Einstein College of Medicine and Montefiore Medical Center  Bronx New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5559-7682","authenticated-orcid":false,"given":"Megan","family":"Buresh","sequence":"additional","affiliation":[{"name":"Division of Addiction Medicine Johns Hopkins School of Medicine  Baltimore Maryland USA"},{"name":"Department of Epidemiology Johns Hopkins School of Public Health  Baltimore Maryland USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meghan T.","family":"O'Brien","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Hospital Medicine University of California San Francisco and San Francisco General Hospital  San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Snyder","sequence":"additional","affiliation":[{"name":"Family Community Medicine University of California, San Francisco  San Francisco California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8005-4727","authenticated-orcid":false,"given":"Shoshana J.","family":"Herzig","sequence":"additional","affiliation":[{"name":"Department of Medicine Harvard Medical School  Boston Massachusetts USA"},{"name":"Department of Medicine Massachusetts General Hospital  Charlestown Massachusetts USA"},{"name":"Department of Medicine Beth Israel Deaconess Medical Center  Boston Massachusetts USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,7,26]]},"reference":[{"key":"e_1_2_7_2_1","unstructured":"SAaMHS Administration.Key Substance Use and Mental Health Indicators in the United States: Results from the 2019 National Survey on Drug Use and Health.SAaMHS Administration;2020.https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/reports\/rpt35319\/2020NSDUHFFR1PDFW102121.pdf"},{"key":"e_1_2_7_3_1","unstructured":"Drug overdose deaths in the U.S. Top 100 000 annually[press release]. Centers for Disease Control and Prevention;\u00a02021.https:\/\/www.cdc.gov\/nchs\/pressroom\/nchs_press_releases\/2021\/20211117.htm"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.5469"},{"key":"e_1_2_7_5_1","doi-asserted-by":"crossref","unstructured":"SuenLW MakamAN SnyderHR et al.National prevalence of alcohol and other substance use disorders among emergency department visits and hospitalizations: NHAMCS 2014\u20132018.J Gen Intern Med.2021;1\u20109.","DOI":"10.1007\/s11606-021-07069-w"},{"key":"e_1_2_7_6_1","doi-asserted-by":"crossref","unstructured":"KingC CookR KorthuisPT MorrisCD EnglanderH.Causes of death in the 12\u200amonths after hospital discharge among patients with opioid use disorder.J Addict Med. Published online September 10 2021.doi:10.1097\/ADM.0000000000000915","DOI":"10.1097\/ADM.0000000000000915"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.7326\/M17-3107"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j1550"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1111\/jrh.12307"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2020.107968"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2019.0876"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.20391"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2021.109089"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2020.1748169"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-020-05815-0"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.3711"},{"key":"e_1_2_7_17_1","first-page":"E1","article-title":"A call to action: hospitalists' role in addressing substance use disorder","volume":"14","author":"Englander H","year":"2019","journal-title":"J Hosp Med"},{"key":"e_1_2_7_18_1","unstructured":"PRISMA.\u00a0Transparent Reporting of Systematic Reviews and Meta\u2010Analyses.Welcome to the Preferred Reporting Items for Systematic Reviews and Meta\u2010Analyses (PRISMA)\u00a02021. Accessed June 26 2022.http:\/\/www.prisma-statement.org\/"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.286.12.1461"},{"key":"e_1_2_7_20_1","unstructured":"EndNote. 2021. Accessed December 11 2021.\u00a0https:\/\/endnote.com\/"},{"key":"e_1_2_7_21_1","doi-asserted-by":"crossref","unstructured":"GrahamR MancherM WolmanD GreenfieldS SteinbergE Institute of Medicine (US) Committee on Standards for Developing Trustworthy Clinical Practice Guidelines.\u00a0Clinical Practice Guidelines We Can Trust.National Academies Press;2011.","DOI":"10.17226\/13058"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.090449"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.091714"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.091716"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.7326\/M16-2953"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2014.01.494"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0b013e3182312983"},{"key":"e_1_2_7_28_1","unstructured":"National Institute for Health and Care Excellence.\u00a0Needle and Syringe Programmes (PH52).National Institute for Health and Care Excellent;2019."},{"key":"e_1_2_7_29_1","first-page":"1","article-title":"The ASAM National Practice Guideline for the treatment of opioid use disorder 2020 focused update","volume":"14","author":"Cunningham CEM","journal-title":"J. Addict. Med"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1213\/ANE.0000000000004018"},{"key":"e_1_2_7_31_1","unstructured":"GowingLAR DunlopA FarrellM LintzerisN.\u00a0National Guidelines for Medication\u2010Assisted Treatment of Opioid Dependence.Commonwealth of Australia;2014."},{"key":"e_1_2_7_32_1","unstructured":"ComerS CunninghamC FishmanMJ et al.\u00a0The ASAM National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use; 2015."},{"key":"e_1_2_7_33_1","unstructured":"HandfordCKM SrivastavaA CironeS et al.\u00a0Buprenorphine\/Naloxone for Opioid Dependence: Clinical Practice Guideline; 2012."},{"key":"e_1_2_7_34_1","unstructured":"WoodEAK FairbairnN HeringR et al.\u00a0CRISM National Guideline for the Clinical Management of Opioid Use Disorder Canadian Research Initiative in Substance Misuse.Canadian Institutes of Health Research;2018."},{"key":"e_1_2_7_35_1","unstructured":"British Columbia Centre on Substance Use.\u00a0A Guideline for the Clinical Management of Opioid Use Disorder.British Columbia Ministry of Health;2017."},{"key":"e_1_2_7_36_1","unstructured":"National Institute for Health and Care Excellence.Needle and syringe programmes (PH52).National Institute for Health and Care Excellent;2014."},{"key":"e_1_2_7_37_1","unstructured":"New South Wales Ministry of Health.New South Wales Clinical Guidelines: Treatment of Opioid Dependence.New South Wales Ministry of Health;2018."},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bja.2019.03.044"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.5770\/cgj.23.420"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2015.1012613"},{"key":"e_1_2_7_41_1","unstructured":"Clinical Guidelines on Drug Misuse and Dependence Update 2017 Independent Expert Working Group.\u00a0Drug Misuse and Dependence: UK Guidelines on Clinical Management.United Kingdom Department of Health;\u00a02017."},{"key":"e_1_2_7_42_1","unstructured":"Department of Veterans Affairs.VA\/DoD Clinical Practice Guideline for Management of Substance Use Disorders.U.S. Department of Defense;2015."},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.3109\/15622975.2011.561872"},{"issue":"2","key":"e_1_2_7_44_1","first-page":"1","article-title":"The ASAM National Practice Guideline for the Treatment of Opioid Use Disorder: 2020 Focused Update","volume":"14","year":"2020","journal-title":"J Addict Med"},{"issue":"5","key":"e_1_2_7_45_1","first-page":"321","article-title":"Managing opioid use disorder in primary care: PEER simplified guideline","volume":"65","author":"Korownyk C","year":"2019","journal-title":"Can Fam Physician"},{"issue":"5","key":"e_1_2_7_46_1","first-page":"e194","article-title":"Opioid use disorder in primary care: PEER umbrella systematic review of systematic reviews","volume":"65","author":"Korownyk C","year":"2019","journal-title":"Can Fam Physician"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000166"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.170958"},{"key":"e_1_2_7_49_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-027374"},{"key":"e_1_2_7_50_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.8020"},{"key":"e_1_2_7_51_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.21381"},{"key":"e_1_2_7_52_1","doi-asserted-by":"publisher","DOI":"10.1080\/02791072.2003.10400007"},{"key":"e_1_2_7_53_1","doi-asserted-by":"crossref","unstructured":"MattickRP BreenC KimberJ DavoliM.Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.Cochrane Database Syst Rev. Published online February 6 2014.doi:10.1002\/14651858.CD002207","DOI":"10.1002\/14651858.CD002207.pub4"},{"key":"e_1_2_7_54_1","unstructured":"U.S. Department of Justice Civil Rights Division.\u00a0The Americans with Disabilities Act and the Opioid Crisis: Combating Discrimination Against People in Treatment or Recovery.U.S. Department of Justice Civil Rights Division;2022."},{"key":"e_1_2_7_55_1","unstructured":"U.S. Attorney's Office \u00a0District of Massachusetts.\u00a0U.S. Attorney's Office Settles Disability Discrimination Allegations with Operator of Skilled Nursing Facilities.United States Attorney's Office District of Massachusetts; 2019."},{"key":"e_1_2_7_56_1","doi-asserted-by":"crossref","unstructured":"VarshneyaNB ThakrarAP HobelmannJG DunnKE HuhnAS.Evidence of buprenorphine\u2010precipitated withdrawal in persons who use fentanyl.J Addict Med. Published online November 23 2021.doi:10.1097\/ADM.0000000000000922","DOI":"10.1097\/ADM.0000000000000922"},{"key":"e_1_2_7_57_1","doi-asserted-by":"crossref","unstructured":"CohenSM WeimerMB LevanderXA PeckhamAM TetraultJM MorfordKL.Low dose initiation of buprenorphine: a narrative review and practical approach.J Addict Med. Published online December 23 2021.doi:10.1097\/ADM.0000000000000945","DOI":"10.1097\/ADM.0000000000000945"},{"key":"e_1_2_7_58_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2021.17128"},{"issue":"6","key":"e_1_2_7_59_1","first-page":"101","article-title":"Community\u2010based opioid overdose prevention programs providing naloxone\u2014United States, 2010","volume":"61","author":"Centers for Disease Control and Prevention","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"e_1_2_7_60_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1360-0443.2009.02724.x"},{"key":"e_1_2_7_61_1","doi-asserted-by":"crossref","unstructured":"MayetS FarrellM FerriM AmatoL DavoliM.Psychosocial treatment for opiate abuse and dependence.Cochrane Database Syst Rev. Published online January 25 2005.doi:10.1002\/14651858.CD004330","DOI":"10.1002\/14651858.CD004330"},{"key":"e_1_2_7_62_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000193"},{"key":"e_1_2_7_63_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0244401"},{"key":"e_1_2_7_64_1","doi-asserted-by":"publisher","DOI":"10.1080\/00952990.2020.1780602"},{"key":"e_1_2_7_65_1","unstructured":"SAMHSA.\u00a0Double jeopardy: COVID\u201019 and behavioral health disparities for Black and Latino communities in the US.Substance Abuse and Mental Health Services Administration;2020."},{"key":"e_1_2_7_66_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jsat.2021.108551"},{"key":"e_1_2_7_67_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.5852"},{"key":"e_1_2_7_68_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1526-4637.2011.01310.x"},{"key":"e_1_2_7_69_1","doi-asserted-by":"publisher","DOI":"10.1080\/08897077.2022.2074601"},{"key":"e_1_2_7_70_1","unstructured":"SAMHSA.The Opioid Crisis and the Black\/African American Population: An Urgent Issue.Office of Behavioral Health Equity;2020."},{"key":"e_1_2_7_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02252-2"},{"key":"e_1_2_7_72_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.12562"},{"key":"e_1_2_7_73_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annemergmed.2020.06.049"},{"key":"e_1_2_7_74_1","doi-asserted-by":"publisher","DOI":"10.1097\/ADM.0000000000000635"},{"key":"e_1_2_7_75_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.6774"},{"key":"e_1_2_7_76_1","doi-asserted-by":"crossref","unstructured":"EnglanderH JonesA KrawczykN et al.A taxonomy of hospital\u2010based addiction care models: a scoping review and key informant interviews.J Gen Intern Med. Published online May 9 2022.doi:10.1007\/s11606-022-07618-x","DOI":"10.1007\/s11606-022-07618-x"}],"container-title":["Journal of Hospital Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jhm.12908","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jhm.12908","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/shmpublications.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jhm.12908","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T14:44:11Z","timestamp":1760625851000},"score":1,"resource":{"primary":{"URL":"https:\/\/shmpublications.onlinelibrary.wiley.com\/doi\/10.1002\/jhm.12908"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,26]]},"references-count":75,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["10.1002\/jhm.12908"],"URL":"https:\/\/doi.org\/10.1002\/jhm.12908","archive":["Portico"],"relation":{},"ISSN":["1553-5592","1553-5606"],"issn-type":[{"value":"1553-5592","type":"print"},{"value":"1553-5606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,26]]},"assertion":[{"value":"2022-01-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-22","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-07-26","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}